Lv59
1560 积分 2022-12-28 加入
Role of Glucagon-Like Peptide-1 on Amyloid, Tau, and α-Synuclein: Target Engagement and Rationale for the Development in Neurodegenerative Disorders
2天前
已完结
Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
3天前
已完结
Causal influences of testosterone on brain structure change rate: A sex-stratified Mendelian randomization study
11天前
已完结
Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical study
19天前
已完结
A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson′s disease by increasing expression of BNDF
19天前
已完结
Development of Midbrain Dopaminergic Neurons and the Advantage of Using hiPSCs as a Model System to Study Parkinson’s Disease
19天前
已完结
Repurposing GLP-1 Receptor Agonists for Parkinson’s Disease: Current Evidence and Future Opportunities
19天前
已完结
Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
20天前
已完结
Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations
24天前
已完结
Where's the Leak in Vascular Barriers? A Review
25天前
已完结
皖公网安备34019202002308
